See up to 3 months of VIVS. The 7-day demo opens the 1M and 3M ranges and puts VIVS on your watchlist.
Start 7-day demoLatest VIVS insider trades
About VivoSim Labs, INC. (VIVS)
The SEC lists VivoSim Labs, INC. under CIK 0001497253, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector. A registration statement was filed on 27 March 2026. No offering has priced.
VIVS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 10,000 | $3K |
VIVS insider transactions (Form 4)
99 Form 4 filings on record, the earliest from Aug 11, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Tony Serge Lialin - Officer | Open-market purchase | Common Stock | 10,000 | $0.28 | $3K | |
| Douglas Jay Cohen | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| ||||||
| Keith Murphy - Officer | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| ||||||
| Alison Tjosvold Milhous | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| ||||||
| David Gobel | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| ||||||
 Adam K. Stern | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| ||||||
| Amar Akhtar Sethi - Officer | Grant or award | Options (right to buy) | 53,500 | $0.00 | - | |
| David Gobel | Open-market sale | Common Stock | 3,266 | $2.24 | $7K | |
| Tony Serge Lialin - Officer | Grant or award | Options (right to buy) | 40,000 | $0.00 | - | |
VIVS insider trading FAQ
What is the latest insider trade for VIVS?
VivoSim Labs, INC. (VIVS) had 1 insider filing in the last 90 days, with the most recent on 2026-09-01. The full record for VIVS runs to 9 Form 4 filings, the earliest from 2025-08-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VIVS stock?
1 insider purchase of VIVS was filed in the last 90 days, totaling $3K.
How many insiders are selling VIVS stock?
No insider sales of VIVS were filed in the last 90 days. 1 sale is on record for this company.
Where can I see VIVS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VIVS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
9The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Tony Serge Lialin view on EDGAR
- - Douglas Jay Cohen view on EDGAR
- - Keith Murphy view on EDGAR
- - Alison Tjosvold Milhous view on EDGAR
- - David Gobel view on EDGAR
- - Adam K. Stern view on EDGAR
- - Amar Akhtar Sethi view on EDGAR
- - David Gobel view on EDGAR
- - Tony Serge Lialin view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where VIVS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VIVS with a 7-day demo
- VIVS on your watchlist
- Every VIVS Form 4 filing on record
- Up to 3 months of VIVS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
